Original Research
Accepted on 25 Sep 2024
Molecular Insights and Inhibitory Dynamics of Flavonoids in Targeting Pim-1 Kinase for Cancer Therapy
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1440958
Volumes
23,939 Publications
Volume 15 - 2024
Review
Accepted on 25 Sep 2024
Attenuating Mitochondrial Dysfunction-Derived Reactive Oxygen Species and Reducing Inflammation: The Potential of Daphnetin in the Viral Pneumonia Crisis
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477680
Original Research
Published on 25 Sep 2024
Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma in vivo
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468920
- 209 views
Systematic Review
Published on 25 Sep 2024
Systematic review of Janus kinases inhibitors for rheumatoid arthritis: methodology, reporting, and quality of evidence evaluation
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1459511
Original Research
Published on 25 Sep 2024
The dose of remimazolam combined with sufentanil for the induction of general anesthesia in obese patients undergoing bariatric surgery: an up-and-down sequential allocation trial
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411856
Review
Published on 25 Sep 2024
Hydrogel-based formulations for urothelial cancer therapy
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1478394
Original Research
Published on 25 Sep 2024
Eucalyptus essential oil exerted a sedative-hypnotic effect by influencing brain neurotransmitters and gut microbes via the gut microbiota-brain axis
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1464654
Systematic Review
Published on 25 Sep 2024
Mapping the evolution and research landscape of ferroptosis-targeted nanomedicine: insights from a scientometric analysis
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477938
- 118 views
Review
Published on 25 Sep 2024
Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1473939
Original Research
Published on 25 Sep 2024
Airspaces-derived exosomes contain disease-relevant protein signatures in a mouse model of cystic fibrosis (CF)-like mucoinflammatory lung disease
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1460692
- 104 views
Original Research
Published on 25 Sep 2024
Global trends and topics in CDK7 inhibitor research: a bibliometric analysis
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1426988
- 111 views
Original Research
Published on 25 Sep 2024
Neuroprotective effects of Gastrodia elata Blume on promoting M2 microglial polarization by inhibiting JNK/TLR4/T3JAM/NF-κB signaling after transient ischemic stroke in rats
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1469602
Review
Accepted on 24 Sep 2024
Isoliquiritigenin as a Modulator of the Nrf2 Signaling Pathway: Potential Therapeutic Implications
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1395735
Original Research
Accepted on 24 Sep 2024
Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1367830
Systematic Review
Accepted on 24 Sep 2024
Management of Blood Lipids in Post-kidney Transplant Patients: A Systematic Review and Network Meta-Analysis
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1440875
Editorial
Accepted on 24 Sep 2024
Editorial: Reviews In Neuropharmacology 2023: Microbiota Gut-Brain Axis, Therapeutic Insights for Neurodegenerative Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1499072